You might reference published trials or ongoing research, including their limitations
In 2009, 29% of 202 human alleles of GPR42 were shown to have an inactivating single nucleotide polymorphism (SNP) at W174, and 61% with an arginine in like GPR41, resulting in a fully functional receptor, differing from it by only 5 aminoacids (312)
This observation led them to speculate that GLP-1 analogs might possess distinct neurotrophic properties and exert protective effects specifically on the nerve
So you kind of age up with your patients in general
147 Additionally, multiple clinical studies have reported the associations between plasma TMAO levels and their dynamic changes and stroke risk, severity, and long-term adverse outcomes
2023: Class action lawsuits are initiated, alleging that Novo Nordisk failed to provide adequate warnings about the risk of serious side effects such as gastroparesis, pancreatitis, and gallbladder disease